Effect of Plasmodium yoelii Exposure on Vaccination with the 19-Kilodalton Carboxyl Terminus of Merozoite Surface Protein 1 and Vice Versa and Implications for the Application of a Human Malaria Vaccine

被引:9
作者
Wipasa, Jiraprapa [1 ,2 ]
Xu, Huji [1 ,3 ]
Liu, Xueqin [1 ]
Hirunpetcharat, Chakrit [4 ]
Stowers, Anthony [5 ]
Good, Michael F. [1 ]
机构
[1] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia
[2] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50200, Thailand
[3] Second Mil Med Univ, Changzheng Hosp, Shanghai 200003, Peoples R China
[4] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok 10400, Thailand
[5] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
PROTECTIVE IMMUNITY; CROSS-REACTIVITY; AOTUS MONKEYS; TH CELLS; FALCIPARUM; FRAGMENT; MICE; IMMUNOGENICITY; ANTIBODIES; INFECTION;
D O I
10.1128/IAI.01063-08
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is well known that exposure to one antigen can modulate the immune responses that develop following exposure to closely related antigens. It is also known that the composition of the repertoire can be skewed to favor epitopes shared between a current infection and a preceding one, a phenomenon referred to as "original antigenic sin." It was of interest, therefore, to investigate the antibody response that develops following exposure to the malaria vaccine candidate homologue Plasmodium yoelii MSP1(19) in mice that had previously experienced malaria infection and vice versa. In this study, preexposure of mice to Plasmodium yoelii elicited native anti-MSP1(19) antibody responses, which could be boosted by vaccination with recombinant MSP1(19). Likewise, infection of MSP1(19)-primed mice with P. yoelii led to an increase of anti-MSP1(19) antibodies. However, this increase was at the expense of antibodies to parasite determinants other than MSP1(19). This change in the balance of antibody specificities significantly affected the ability of mice to withstand a subsequent infection. These data have particular relevance to the possible outcome of malaria vaccination for those situations where the vaccine response is suboptimal and suggest that suboptimal vaccination may in fact render the ultimate acquisition of natural immunity more difficult.
引用
收藏
页码:817 / 824
页数:8
相关论文
共 19 条
[1]  
DALY TM, 1995, J IMMUNOL, V155, P236
[2]  
DESTGROTH SF, 1967, COLD SPRING HARB SYM, V32, P525
[3]   Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys [J].
Egan, AF ;
Blackman, MJ ;
Kaslow, DC .
INFECTION AND IMMUNITY, 2000, 68 (03) :1418-1427
[4]   INFLUENZA - THE NEWE ACQUAYANTANCE [J].
FRANCIS, T .
ANNALS OF INTERNAL MEDICINE, 1953, 39 (02) :203-221
[5]   Genetic diversity and antigenic polymorphism in Plasmodium falciparum:: Extensive serological cross-reactivity between allelic variants of merozoite surface protein 2 [J].
Franks, S ;
Baton, L ;
Tetteh, K ;
Tongren, E ;
Dewin, D ;
Akanmori, BD ;
Koram, KA ;
Ranford-Cartwright, L ;
Riley, EM .
INFECTION AND IMMUNITY, 2003, 71 (06) :3485-3495
[6]   Pathways and strategies for developing a malaria blood-stage vaccine [J].
Good, MF ;
Kaslow, DC ;
Miller, LH .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :57-87
[7]  
Hirunpetcharat C, 1999, J IMMUNOL, V162, P7309
[8]   Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice [J].
Hirunpetcharat, C ;
Stanisic, D ;
Liu, XQ ;
Vadolas, J ;
Strugnell, RA ;
Lee, R ;
Miller, LH ;
Kaslow, DC ;
Good, MF .
PARASITE IMMUNOLOGY, 1998, 20 (09) :413-420
[9]  
Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400
[10]   ANTIGEN-SPECIFIC IMMUNOSUPPRESSION IN HUMAN MALARIA DUE TO PLASMODIUM-FALCIPARUM [J].
HO, M ;
WEBSTER, HK ;
LOOAREESUWAN, S ;
SUPANARANOND, W ;
PHILLIPS, RE ;
CHANTHAVANICH, P ;
WARRELL, DA .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (04) :763-771